Running a BBC wheel strategy lets you generate consistent premium income on Virtus Biotech Clinical Trials ETF while setting your own entry and exit prices on the underlying. Virtus Biotech Clinical Trials ETF's wheel combines cash-secured puts and covered calls into a repeatable cycle: sell puts at strikes where you'd be happy to own BBC, and if assigned, sell calls at strikes where you'd be happy to sell. Use our scanner to find the best BBC wheel strategy setups in real time.
The wheel works best on liquid, high-quality names with stable fundamentals and active options markets — exactly the profile many large-cap leaders fit. The mechanics are simple: sell a cash-secured put on BBC, collect premium, and either keep the premium if it expires worthless or take assignment at a discount to current price. Once assigned, sell covered calls against the shares to keep collecting premium until they're called away. Choosing the right strikes, expirations, and IV environment is what separates a profitable BBC wheel from a losing one.
The Fund seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index, which tracks the performance of select clinical trials stage biotechnology companies.Effective February 27, this Fund's name changed from Virtus LifeSci Biotech Clinical Trials ETF to Virtus Biotech Clinical Trials ETF.
The difference between a wheel that compounds and one that bleeds comes down to strike selection, IV timing, and discipline on assignment. Our scanner handles the heavy lifting: it ranks every leg of the BBC wheel strategy by delta, premium yield, IV rank, and days to expiration, so you can deploy capital where the math works. Build your BBC wheel strategy on data, not gut feel — and let the options wheel do what it does best: pay you to wait.
